Mirum Pharmaceuticals (MIRM) Non Operating Income (2019 - 2025)

Mirum Pharmaceuticals' Non Operating Income history runs 7 years deep, the most recent figure standing at -$218000.0 for Q4 2025.

• In Q4 2025, Non Operating Income fell 194.37% year-over-year to -$218000.0; the TTM figure through Mar 2026 stood at $263000.0 (down 83.18% YoY), while the FY2025 annual figure was $2.4 million, up 95.47% from the prior year.
• Non Operating Income was -$218000.0 for Q4 2025 at Mirum Pharmaceuticals, down from $395000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.1 million in Q1 2025 to a low of -$3.1 million in Q4 2023.
• Historically, Non Operating Income has averaged $27150.0 across 5 years, with a median of -$26000.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Non Operating Income slumped 3358.82% in 2022, then surged 788.54% in 2023.
• A 5-year view of Non Operating Income shows it stood at -$17000.0 in 2021, then plunged by 3358.82% to -$588000.0 in 2022, then tumbled by 420.58% to -$3.1 million in 2023, then jumped by 107.55% to $231000.0 in 2024, then sank by 194.37% to -$218000.0 in 2025.
• The last three Non Operating Income figures came in at -$218000.0 (Q4 2025), $395000.0 (Q3 2025), and $86000.0 (Q2 2025), per Business Quant data.